Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

JNCE Stock Annual Income Statement. Download in Excel

Jounce Therapeutics Inc. logo

Jounce Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

1.88
 
USD
  
-0.05
  
(-2.59%)
Previous close: 1.93  Open: 1.91  Bid:   Ask:
52 week range    
0.00   
   0.00
Mkt Cap: 0 M  Avg Vol (90 Days): 0
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 9th December 2024

Stock Rankings

21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

JNCE Income Statement

Annual
Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization268000.0
Amortization of intangibles268000.0
Basic EPS total5 M-0.841.72-1.24-1.82-0.99
Basic weighted shares outstanding30 M33 M33 M35 M50 M52 M
Depreciation-4 M-4 M-4 M-3 M-3 M-2 M
Depreciation unreconciled268000.0
DepreciationAndAmortization268000.0-4 M-4 M-3 M-3 M-2 M
Diluted EPS total-0.57-0.841.66-1.24-1.82-0.99
Diluted weighted shares outstanding33 M34 M35 M50 M52 M
GeneralAndAdministrativeExpense23 M26 M28 M29 M29 M31 M
Gross operating profit72 M65 M148 M62 M27 M82 M
Income before tax-17 M-27 M57 M-44 M-91 M-51 M
Income taxes36000.046000.046000.014000.015000.0135000.0
MiscOtherSpecialCharges3 M4 M4 M1 M199000.01 M
Net income from total operations-17 M-27 M57 M-44 M-91 M-51 M
NetIncomeCommonStockholders-17 M-27 M57 M-44 M-91 M-51 M
NetIncomeContinuousOperations-17 M-27 M57 M-44 M-91 M-51 M
Operating income-19 M-31 M53 M-45 M-91 M-52 M
Operating income before depreciation (EBITDA)-25 M59 M-40 M-87 M-48 M
OperatingExpense91 M96 M95 M107 M118 M134 M
OperatingRevenue72 M65 M148 M62 M27 M82 M
Other income net-3 M-4 M-4 M-1 M-199000.0-1 M
OtherGandA23 M26 M28 M29 M29 M31 M
OtherImpairmentOfCapitalAssets208000.0
RentAndLandingFees23 M26 M28 M29 M29 M31 M
Research & development expense68 M70 M67 M79 M89 M103 M
ResearchExpense68 M70 M67 M79 M89 M103 M
SalariesAndWages-5 M-9 M-10 M-10 M-11 M-10 M
Selling Gen & administrative expense23 M26 M28 M29 M29 M31 M
Special income/charges-318000.0
Total Income available for interest expense (EBIT)-17 M-27 M57 M-44 M-91 M-51 M
Total common shares outstanding52 M52 M52 M52 M52 M52 M
Total net income-17 M-27 M57 M-44 M-91 M-51 M
Total ordinary shares53 M53 M53 M53 M53 M53 M
Total revenues72 M65 M148 M62 M27 M82 M
TotalExpenses91 M96 M95 M107 M118 M134 M
WriteOff318000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University